Enoxaparin thromboprophylaxis during pregnancy: a review of pharmacist-led interventions
DOI:
https://doi.org/10.60988/p.v37i2S.250Keywords:
enoxaparin; thromboprophylaxis; venous thromboembolism; pregnancy; pharmacist-led interventionsAbstract
Enoxaparin, a low-molecular-weight heparin, is a critical agent for anticoagulation during pregnancy due to its efficacy and safety. It is generally used as a prophylactic agent against venous thromboembolism; a particularly serious and dangerous situation when occurring during pregnancy. However, the enoxaparin administration during pregnancy requires accurate dosing and monitoring. Complications as a result of prescribing mistakes highlight the need for competitive control strategies. This review attempts to examine the effects of selected pharmacist-led interventions on enoxaparin-induced thromboprophylaxis in pregnant patients. Based on the findings of studies from the literature, we herein emphasize the crucial role of pharmacists in improving anticoagulation treatment goals, correcting dosing errors, ensuring patient adherence, and protecting from the development of adverse events during antenatal thromboprophylaxis.
References
1. Cox S., Eslick R., McLintock C. Effectiveness and safety of thromboprophylaxis with enoxaparin for prevention of pregnancy-associated venous thromboembolism. J. Thromb. Haemost. 17(7), 1160–1170, 2019. DOI: 10.1111/jth.14452
2. Austin J., Barras M., Sullivan C. Interventions designed to improve the safety and quality of therapeutic anticoagulation in an inpatient electronic medical record. Int. J. Med. Inform. 135, 104066, 2020. DOI: 10.1016/j.ijmedinf.2019.104066
3. Bedouch P., Charpiat B., Conort O., Rose F.X., Escofier L., Juste M., et al. Assessment of clinical pharmacists’ interventions in French hospitals: results of a multicenter study. Ann. Pharmacother. 42(7), 1095–1103, 2008. DOI: 10.1345/aph.1L045
4. Löffler C., Koudmani C., Böhmer F., Paschka S.D., Höck J., Drewelow E., et al. Perceptions of interprofessional collaboration of general practitioners and community pharmacists – a qualitative study. BMC Health Serv. Res. 17(1), 224, 2017. DOI: 10.1186/s12913-017-2157-8
5. Daughety M.M., Zilberman-Rudenko J., Shatzel J.J., McCarty O.J.T., Raghunathan V., DeLoughery T.G. Management of anticoagulation in pregnant women with mechanical heart valves. Obstet. Gynecol. Surv. 75(3), 190–198, 2020. DOI: 10.1097/OGX.0000000000000751
6. Shilbayeh S.A.R. The impact of a pharmacist-led warfarin educational video in a Saudi setting. J. Pharm. Bioallied Sci. 12(4), 413–422, 2020. DOI: 10.4103/jpbs.JPBS_188_20
7. Ahmed N.O., Osman B., Abdelhai Y.M., El-Hadiyah T.M.H. Impact of clinical pharmacist intervention in anticoagulation clinic in Sudan. Int. J. Clin. Pharm. 39(4), 769–773, 2017. DOI: 10.1007/s11096-017-0475-x
8. Obaid D., El-Dahiyat F., Babar Z.U. Pharmacy practice and clinical pharmacy research in the Middle East: a scoping review of studies from Bahrain, Iraq, Jordan, Kuwait, Lebanon, Oman, Palestine, Qatar, Saudi Arabia, Syria, United Arab Emirates, and Yemen. J. Pharm. Policy Pract. 15(1), 40, 2022. DOI: 10.1186/s40545-022-00434-y
9. Mikhael E.M., Nassir K.F., Alkhaqani A.L., Jabbar Z.R. Effectiveness of pharmacist-led nurse education on enoxaparin injection technique in Baghdad Teaching Hospital, Iraq. Al-Rafidain J. Med. Sci. 6(1), 202–207, 2024. DOI: 10.54133/ajms.v6i1.622
10. Suker S.E.J., Al-Ameen A.A.H., Hadi N.R. Evaluating the current practice of post cesarean thromboprophylaxis and enhancing guideline adherence in Al-Najaf hospitals. Med. Arch. 75(5), 351–355, 2021. DOI: 10.5455/medarh.2021.75.351-355
